Mounjaro Price Guide: What Drives the Monthly Cost

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Type "Mounjaro cost" into any search bar and you get a wall of conflicting numbers. That is because there is no single price. What one person pays at the pharmacy counter can look nothing like their neighbor's receipt for the identical prescription. This guide, part of the PlexusDx Education Hub, unpacks the moving parts behind the number so the quotes you see online start to make sense.

Start with the list price, then ignore it

As of April 2026, Mounjaro carries a U.S. list price of roughly $1,069 per month according to Eli Lilly's published pricing. Think of that figure as a ceiling, not a forecast. Rebates negotiated between manufacturers and payers, insurance benefits, savings cards, and pharmacy-level pricing all sit between that sticker and the amount an insured patient actually hands over. Very few people pay full list.

How your plan rewrites the math

Whether a commercial plan pays anything hinges on the indication written on the prescription and that plan's formulary and prior-authorization rules. Coverage for type 2 diabetes is common. Coverage tied to chronic weight management is far more variable, frequently gated behind BMI thresholds and prior authorization, and sometimes excluded outright. Medicare, as of April 2026, does not pay for FDA-approved weight-management drugs on the basis of weight alone, though some cardiovascular indications are covered. The only reliable answer comes from calling your plan directly.

Savings cards versus coupon platforms

These are two different tools. Eli Lilly publishes a manufacturer savings card that can meaningfully lower monthly out-of-pocket costs for eligible commercially insured patients, though it typically excludes Medicare, Medicaid, and TRICARE and comes with monthly and annual caps. Separately, discount platforms such as GoodRx and SingleCare list cash-coupon prices that swing from pharmacy to pharmacy. Eligibility and amounts shift often, so confirm both at the time of fill.

The compounding chapter of 2024 and 2025

When the FDA listed semaglutide and tirzepatide as being in shortage, state-licensed 503A compounding pharmacies could legally prepare these molecules. The agency declared the semaglutide shortage resolved in late 2024 and the tirzepatide shortage in early 2025. That narrowed, but did not close, the compounding window. Compounded formulations remain available through licensed pathways where clinically justified, are not identical to the branded product, and are priced on their own terms.

Three cost scenarios in plain terms

With commercial insurance that covers the indication plus an applied savings card, eligible patients may reach as little as $25 per month depending on plan caps. When the plan does not cover the indication, cash cost lands near list price minus any coupon. Without insurance at all, you approach list price, and compounded options through the PlexusDx Weight Management Protocols follow a separate structure posted on each product page.

Where genetics enters the cost conversation

Price is only half of any protocol decision; the other half is metabolic fit. Common variants in FTO and MC4R shape appetite regulation and energy-balance biology long before any prescription is written. The PlexusDx Precision Peptide Genetic Test maps 14 pathways, 49 peptides, 150+ genetic insights so that context sits alongside cost in the conversation. It reads pathway-level traits and does not predict how you will respond to any specific medication. PlexusDx offers semaglutide and tirzepatide, including Tirzepatide Injection, through licensed 503A compounding.

Reading a pharmacy quote without getting misled

Once you understand the drivers, the next skill is interpreting a quote you are actually given. A number without context is nearly meaningless, because the same medication can be quoted several ways depending on how the pharmacy runs it through the system.

Why two quotes for the same drug differ

One quote may reflect your insurance copay after prior authorization, another the cash price with a discount coupon, and a third the pre-insurance list. None of them is wrong; they answer different questions. Before comparing figures across pharmacies or websites, make sure each one is measuring the same thing, or you will compare apples to oranges and reach the wrong conclusion.

Questions worth asking your pharmacist

A pharmacist can tell you whether your plan has processed a prior authorization, whether the quoted price assumes a savings card, and whether a lower cash price exists without insurance. Asking those three questions turns a confusing counter experience into a clear comparison. Because savings-card terms and coupon prices change, confirming them at the moment of fill protects you from acting on a stale figure you saw days earlier.

Keeping your estimate current

Prices in this category move as manufacturer programs, formularies, and coupon rates are revised. An estimate that was accurate last quarter can drift, so treat any figure, including the published list price, as a point-in-time reference rather than a fixed cost. Rechecking with your plan and pharmacy before each fill keeps your budgeting grounded in the number you will actually be charged.

Frequently Asked Questions

What is Mounjaro's list price right now?

As of April 2026, Eli Lilly's published U.S. list price for Mounjaro is approximately $1,069 per month. That figure is the pre-insurance starting point. Rebates, plan benefits, savings cards, and pharmacy pricing routinely change what a patient pays, so confirm the current number with your pharmacy before you fill.

Will my insurance pay for Mounjaro?

It depends on your formulary, the FDA indication on the script, and prior-authorization criteria. Diabetes coverage is widespread; weight-management coverage varies and is often gated by BMI rules or excluded. Medicare does not cover weight-alone indications as of April 2026. Contact your plan for a definitive answer specific to your benefits.

Are compounded versions still an option?

Sometimes. After the FDA resolved the tirzepatide shortage in early 2025, the compounding window narrowed but did not vanish. Licensed 503A pharmacies can still prepare compounded formulations where a clinician judges it appropriate. These products are not identical to the brand and carry their own separate pricing, so discuss suitability with a provider.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.